Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid

The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics

MicrobioTx launches IBS Risk Score to enable early detection of gut disorder

The launch coincides with IBS Awareness Month in April

Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO

Move to accelerate cancer care expansion across India

Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities

PMDA is regarded among the most stringent regulatory bodies globally

Axten Hospitals raises Rs 2.5 crore from PedalStart to scale surgical care network

The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.

Aurobindo Pharma wins USFDA nod for rare disease drug set for immediate launch

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals

Move strengthens footprint in Western India and expands multi-specialty care network